Ironwood Pharmaceuticals Inc expected to post a loss of 1 cent a share - Earnings Preview

Ironwood Pharmaceuticals

05/05/2025 14:22

Ironwood Pharmaceuticals Inc IRWD.OQ IRWD.O is expected to show a fall in quarterly revenue when it reports  results on May 7 (estimated) for the period ending March 31 2025

The Boston Massachusetts-based  company is expected to report a 38.6% decrease in revenue to $45.98 million from $74.88 million a year ago, according to the mean estimate from 5 analysts, based on LSEG data.

​LSEG's mean analyst estimate for Ironwood Pharmaceuticals Inc is for a loss of 1 cent per share.

The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 1 "strong buy" or "buy," 5 "hold" and no "sell" or "strong sell."

The mean earnings estimate of analysts was unchanged in the last three months. ​

Wall Street's median 12-month price target for Ironwood Pharmaceuticals Inc is $1.00​, above​ its last closing price of $0.93. ​​​

Previous quarterly performance (using preferred earnings measure in US dollars). ​

QUARTER ENDING
STARMINESMARTESTIMATE®
LSEG IBES ESTIMATE
ACTUAL
BEAT, MET, MISSED
SURPRISE %
Dec. 31 2024
0.07
0.08
0.02
Missed
-74.4
Sep. 30 2024
0.06
0.08
0.02
Missed
-75.2
Jun. 30 2024
0.13
0.15
0.00
Missed
-100​
Mar. 31 2024
0.15
0.19
-0.02
Missed
-110.5
​​Dec. 31 2023
0.21
0.21
-0.01
Missed
-104.9
Sep. 30 2023
0.17
0.16
0.09
Missed
-42.9​
Jun. 30 2023
0.26
0.25
0.31
Beat
25.7
Mar. 31 2023
0.23
0.24
0.25
Beat
3.1

This summary was machine generated May 5 at 13:22 GMT.  All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)